Department of Medicine

Self named co-principal investigator of Vanderbilt’s Clinical and Translational Science Award

Wesley Self, MD, MPH, a physician-scientist at Vanderbilt University Medical Center, has been named co-principal investigator (co-PI) of Vanderbilt’s Clinical and Translational Science Award (CTSA).  

Reduced exercise capacity in ICU survivors

ICU survivors who have impaired exercise capacity months after discharge may have damaged muscle mitochondria — the energy powerhouses of the cell, Vanderbilt researchers propose.

Bariatric surgery patient Veronica Llamas-Barajas recently received a heart transplant.

Patient’s care journey included LVAD, bariatric surgery, transplant

When Veronica Llamas-Barajas received a heart transplant at Vanderbilt University Medical Center in April, it was the culmination of a seven-year journey.

Members of the newly named MASLAB gathered for a portrait on the Medical Center Plaza. The early lung cancer detection research initiative was named in honor of the late Pierre Massion, MD.

Lung cancer detection program lands grant renewal

The National Cancer Institute has renewed funding for the Early Detection Research Network Lung Cancer Clinical Validation Center at Vanderbilt- Ingram Cancer Center.

The study could suggest ways to promote the transport of phospholipids and cholesterol out of macrophages, immune system cells that play key roles in all stages of atherosclerosis development.

Study suggests new mechanism for lipid transporter

A new model suggests that a protein involved in the generation of high-density lipoprotein (HDL) works differently than previously thought.

Patients had ‘significant and clinically meaningful improvement’ in survival in fruquintinib clinical trial

Patients with metastatic colorectal cancer who had not responded to other treatments had “significant and clinically meaningful improvement” in overall survival when treated with the oral targeted therapy fruquintinib.

1 20 21 22 23 24 92